Another patent for Aquaporin in China

Danish company Aquaporin A/S has received a Notification of Allowance from the Chinese government's State Intellectual Property Office for its patent application titled Methods for Production of Salinity Power.

This follows a similar notification in September 2012 for Aquaporin's patent Membrane for Filtering of Water.

In its annual report released on 13 December 2012, Aquaporin states that these and other patent applications "consolidated its position as world leading in the development of biomimetic membranes for water purification".

Aquaporin now owns 28 issued patents worldwide with more than 100 approved patent claims.

In 2011/2012, says the annual report, Aquaporin made an operating loss of DKr 6.1 million as predicted at the beginning of the year. The company's capital base was strengthened through the supply of capital from its major shareholder, and the company has received financial commitment from the same for all of 2012/2013.

Chairman Søren Bjørn Hansen stated, "Over the coming year, Aquaporin needs to move from a pure R&D focused company to a global, commercial organisation rooted in R&D and ground-breaking innovation. This is a huge task, but the market potential for our revolutionising, patented technology is enormous, and we have all the opportunities of becoming a commercial success."

"A part of the global strategy is the activation of the subsidiary Aquaporin Asia Pte Ltd in Singapore, where the possibilities and conditions for a development company such as Aquaporin are very favourable," said Hansen. "In addition, proximity to major markets in Asia including India, China and Japan is very interesting from a business perspective. It is expected that the Singapore company will be operational from early 2013."

Tags

Aquaporin | Biomimetics | Aquaporin | Patent | Singapore


Click a keyword to see more stories on that topic, view related news, or find more related items.

© Faversham House Group Ltd 2012. Water. desalination + reuse news articles may be copied or forwarded for individual use only. No other reproduction or distribution is permitted without prior written consent.